Hypersensitivity News and Research

RSS
Hypersensitivity is an exaggerated response by the immune system to a drug or other substance.
Autism could be detected early using a hearing test finds research

Autism could be detected early using a hearing test finds research

Noninvasive hearing test may assist with early detection of autism spectrum disorders

Noninvasive hearing test may assist with early detection of autism spectrum disorders

Common food additive could cause celiac disease, review says

Common food additive could cause celiac disease, review says

Novel insight on inflammatory regulation could pave way for effective pain therapies

Novel insight on inflammatory regulation could pave way for effective pain therapies

Study describes mechanism that makes people more vulnerable to hunger-causing stimuli

Study describes mechanism that makes people more vulnerable to hunger-causing stimuli

FDA approves new drug for treatment of rare autoimmune disorder

FDA approves new drug for treatment of rare autoimmune disorder

FDA approves antibacterial drug to treat travelers' diarrhea

FDA approves antibacterial drug to treat travelers' diarrhea

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus announces availability of Arsenic Trioxide Injection in the US

Monash researchers provide insight into intricate peptide changes affecting immune system

Monash researchers provide insight into intricate peptide changes affecting immune system

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

TU Wien develops new remedy for celiac disease

TU Wien develops new remedy for celiac disease

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD